Advanced search
Publication Cover
Future Science OA Volume 9, 2023 - Issue 10
Submit an article Journal homepage
545
Views
2
CrossRef citations to date
0
Altmetric
Case Report

A Primary Hepatic Lymphoma in a Patient with Crohn's Disease Receiving Thiopurine and Anti-TNF Therapy: A Case Report

Salma Merhaben1 Gastroenterology Department, Charles Nicolle hospital, Tunis, 1006, TunisiaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0009-0003-8380-3756
ORCID Icon,
Shema Ayadi1 Gastroenterology Department, Charles Nicolle hospital, Tunis, 1006, Tunisia
,
Monia Tangour2 Histopathology Department, Salah Azaiez Institute, Tunis, 1007, Tunisia
,
Nadia Boujelbene2 Histopathology Department, Salah Azaiez Institute, Tunis, 1007, Tunisia
,
Rayfa Ghariani3 Radiology Department, El Amen private hospital, Nabeul, 8000, Tunisia
,
Leila Mouelhi1 Gastroenterology Department, Charles Nicolle hospital, Tunis, 1006, Tunisia
&
Fathi Merhaben4 Gastroenterology Department, El Amen private hospital, Nabeul, 8000, Tunisia
 show all
Article: FSO893 | Received 21 May 2023, Accepted 02 Aug 2023, Published online: 28 Aug 2023

References

  • NoronhaV , ShafiNQ , ObandoJA , KummarS. Primary non-Hodgkin's lymphoma of the liver. Crit. Rev. Oncol. Hematol.53(3), 199–207 (2005).
  • TurnerD , RicciutoA , LewisAet al.STRIDE-II: an update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD. Gastroenterology160(5), 1570–1583 (2021).
  • AnneseV , BeaugerieL , EganLet al.European evidence-based consensus: inflammatory bowel disease and malignancies. J. Crohns Colitis.9(11), 945–965 (2015).
  • ForrestMS , SkibolaCF , LightfootTJet al.Polymorphisms in innate immunity genes and risk of non-Hodgkin lymphoma. Br. J. Haematol.134(2), 180–183 (2006).
  • KandielA , FraserAG , KorelitzBI , BrensingerC , LewisJD. Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine. Gut54(8), 1121–1125 (2005).
  • HerrintonLJ , LiuL , WengX , LewisJD , HutflessS , AllisonJE. Role of thiopurine and anti-TNF therapy in lymphoma in inflammatory bowel disease. Am. J. Gastroenterol.106(12), 2146–2153 (2011).
  • WilliamsCJM , Peyrin-BirouletL , FordAC. Systematic review with meta-analysis: malignancies with anti-tumor necrosis factor-α therapy in inflammatory bowel disease. Aliment. Pharmacol. Ther.39(5), 447–458 (2014).
  • AndersenNN , PasternakB , BasitSet al.Association between tumor necrosis factor-α antagonists and risk of cancer in patients with inflammatory bowel disease. JAMA311(23), 2406–2413 (2014).
  • LemaitreM , KirchgesnerJ , RudnichiAet al.Association between use of thiopurines or tumor necrosis factor antagonists alone or in combination and risk of lymphoma in patients with inflammatory bowel disease. JAMA318(17), 1679–1986 (2017).
  • NocturneG , BoudaoudS , LyB , PascaudJ , PaolettiA , MarietteX. Impact of anti-TNF therapy on NK cells function and on immunosurveillance against B-cell lymphomas. J. Autoimmun.80, 56–64 (2017).
  • MatsumotoT , MotoyaS , WatanabeKet al.Adalimumab Monotherapy and a Combination with Azathioprine for Crohn's Disease: A Prospective, Randomized Trial. J. Crohns Colitis.10(11), 1259–1266 (2016).
  • SokolH , BeaugerieL , MaynadiéMet al.Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease. Inflamm. Bowel Dis.18(11), 2063–2071 (2012).
  • RezkSA , WeissLM. Epstein–Barr virus–associated lymphoproliferative disorders. Hum. Pathol.38(9), 1293–1304 (2007).
  • BeaugerieL , BrousseN , BouvierAMet al.Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. Lancet Lond. Engl.374(9701), 1617–1625 (2009).
  • SeverynsT , KirchgesnerJ , LambertJet al.Prognosis of lymphoma in patients with known inflammatory bowel disease: a french multicentre cohort study. J. Crohns Colitis.14(9), 1222–1230 (2020).
  • CesarettiM , LoustauM , RobbaC , SenescendeL , ZarzavadjianLe Bian A. Reappraisal of primary hepatic lymphoma: is surgical resection underestimated?Crit. Rev. Oncol. Hematol.123, 1–6 (2018).
  • QiuM-J , FangX-F , HuangZ-Zet al.Prognosis of primary hepatic lymphoma: a US population-based analysis. Transl. Oncol.14(1), Doi: 10.1016/j.tranon.2020.100931 (2021).
  • HaiderFS , SmithR , KhanS. Primary hepatic lymphoma presenting as fulminant hepatic failure with hyperferritinemia: a case report. J. Med. Case Reports.2(1), 279 (2008).

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.